Journal
CANCER RESEARCH
Volume 65, Issue 20, Pages 9155-9158Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-05-2553
Keywords
-
Categories
Funding
- NCI NIH HHS [R01-CA-101227-01, P50-CA58223-09A1] Funding Source: Medline
- NCRR NIH HHS [M01RR00046] Funding Source: Medline
- NIEHS NIH HHS [U19-ES11391-03] Funding Source: Medline
Ask authors/readers for more resources
Microarray analysis has been shown to improve risk stratification of breast cancer. Breast tumors analyzed by hierarchical clustering of expression patterns of intrinsic genes have been reported to subdivide into at least four molecular subtypes that are associated with distinct patient outcomes. Using a supervised method, a 70-gene expression profile has been identified that predicts the later appearance or absence of clinical metastasis in young breast cancer patients. Here, we show that distant metastases display both the same molecular breast cancer subtype as well as the 70-gene prognosis signature as their primary tumors. Our results suggest that the capacity to metastasize is an inherent feature of most breast cancers. Furthermore, our data imply that poor prognosis breast carcinomas classified either by the intrinsic gene set or the 70 prognosis genes represent distinct disease entities that seem sustained throughout the metastatic process.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available